MARKET OVERVIEW
Insulin controls the body's fat and glucose metabolism. It is a peptide hormone that is secreted by beta cells in the islets of Langerhans in the pancreas and helps in glucose metabolism regulation. It promotes glucose to be absorbed from the blood by skeletal muscle cells and fat tissues. But due to some diseases and disorders body not able to make sufficient amout of insulin and which results in hyperglycemia due to imbalnced metabollism. In such conditions insulin is given externally to maintain normal blood glucose levels.
MARKET SCOPE
The "Global Insulin Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the insulin market with detailed market segmentation by drug product and indication. The report provides key statistics on the market status of the leading insulin market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on product the market is segmented as, short acting insulin, intermediate acting insulin, long acting insulin, premixed insulin, fast acting insulin.
- Based on indication the market is segmented as, type 1 diabetes, type 2 diabetes, gestational diabetes and prediabetes.
MARKET DYNAMICS
Drivers:
- Growing prevalence of diabetes across the globe along with rising geriatric population across the globe.
- Presence of risk factors such as, obesity, unhealthy lifestyles are also expected to spur the market growth during the forecast period.
- Technological advancements and high R&D investments by pharmaceutical and biopharmaceutical companies.
Restraints:
- However, high cost of production along with presence of stringent regulatory guidelines are expected to restrain market growth during the forecast period.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The insulin market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the insulin market in these regions.
IMPACT OF COVID-19 ON INSULIN MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. COVID-19 has brought several changes in lives of people with diabetes mellitus. Due to lockdown scenes the daily routine of diabetes patient disrupted they became more sedan and practicing unhealthy diets. COVID-19 outbreak enforced lockdowns in several areas which affected to hospital visits of diabetic patients thus has ultimately affected the demand of insulin and other diabetes therapeutics. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the insulin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from insulin market are anticipated to lucrative growth opportunities in the future with the rising demand for insulin in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the insulin market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- sanofi-aventis U.S. LLC
- Novo Nordisk A/S
- Biocon
- Lilly
- Wockhardt
- Bioton
- Julphar
- MannKind Corporation
- USV Private Limited
- Ypsomed Holding
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.